Introduction
In many mature organs, a portion of the cells in the connective tissue remains undifferentiated. Those ®broblast-like cells, or stromal cells, can terminally differentiate upon hormonal stimulation due to physiology changes, non-neonatal development, or when tissue repair is required. The reserved`stem cells' play important roles in tissue remodeling and growth 1 as well as tumor development. 2 In the adult organism, bone marrow stromal cells retain the potential to differentiate along multiple mesodermal lineages, including adipocytes, chondrocytes, myocytes and osteoblasts. 3 Conversely, the potential of adipose derived stromal cells remains unclear. We demonstrate here that the stromal cells from adipose tissue are accessible, can be isolated and cultured ef®ciently, and can form adipocyte or osteoblast in vitro. The adipose stromal cells, therefore, represent a potential source for several tissue engineering approaches.
Bone marrow stromal cells
The most extensively studied stromal cells have been isolated from the bone marrow. The bone marrow is a unique microenvironment which contains a diverse array of cell types. These include the hematopoietic stem cells and their lineage-differentiated progeny, hematopoietic-supporting stromal cells, adipocytes and osteoblasts. These cells must achieve homeostasis within a con®ned hard tissue structure while serving at least three major functions: hematopoiesis, osteogenesis and adipogenesis. 4 These mesodermal-derived cells, referred to as the`stromal' cells in this manuscript, are capable of differentiating into both adipocytes and osteoblasts. These progenitors have been described in both rodent and human marrow cultures. 4 Recent studies have demonstrated that individual clones of human bone marrow stromal cells can differentiate into osteoblasts, adipocytes, and chondrocytes in vitro 5 ± 7 Moreover, cells derived from a single human stromal cell colony can form bone when transplanted into immunode®cient mice. 7 These ®nd-ings suggest a potential cell-based clinical procedure to repair monolingual fractures in elderly and osteoporotic patients.
The adipose stromal cells
The most abundant source of accessible stroma, however, is from the adipose tissue. The surgical procedure of obtaining subcutaneous adipose is relatively noninvasive and can be performed in outpatient clinics. The isolation of adipose stromal cells was ®rst described by Van and Roncari 8 using type I collagenase to digest the extracellular matrices. The¯oating primary adipocytes could be separated by centrifugal force from the cells that settle down, the stromal ± vascular (SV) fraction. The SV fraction includes the stromal cells, the blood cells and the blood vessel cells. Without pre-coating the culture wear and supplementing endothelial growth hormones, the capillary endothelial cells do not attach or grow well. After overnight culture to allow adhering, between 10000 and 25000 stromal cells per gram of adipose tissue can be isolated. The yield of stromal cells could be in¯uenced by the surgical procedures as well as the age and physical conditions of the patient. 9 The stromal cells proliferate when supplemented with fetal bovine serum or combination of growth hormones. The isolated stromal cells can be expanded by several passages, though the doubling time at each passage is prolonged and the surface area of each cell enlarges, which makes continued expansion of cells not cost and time effective (Table 1 ). The ability of the cells to terminally differentiate is also reduced after prolonged growth in tissue culture (Halvorsen, unpublished data). The number of cells that can be obtained from adipose tissue, however, is suf®cient for many applications (Table 1) . On average, there are three to four doublings per passage. If the cells are terminally differentiated at passage 2, they have gone through less than 10 doublings in culture and cells are ready at approximately 15 days post-surgery.
Cultured adipocytes
The stromal cells differentiate to mature adipocytes by hormonal induction in chemically de®ned media, though the differentiation ef®ciency varies from 25% to 70%. 9 The differentiation ef®ciency can be signi®cantly improved when a potent peroxisome proliferator activated receptor gamma (PPARg) agonist is included in the culture medium, 10 (Halvorsen, unpublished data). In response to such adipogenic agonists, these cells accumulate lipid and express many of the standard adipocyte gene markers identi®ed in peripheral adipose tissue. Transcription factors such as PPARg and CaEBPa regulate these events. During differentiation, the morphology of the cells changes dramatically due to the accumulation of lipid droplets ( Figure 1) The expression of genes encoding cytoskeletal proteins decreases and adipocyte-speci®c proteins increase, as demonstrated by cDNA microarray analysis (Table 2   11 ).
Differentiation of stromal cells into osteoblasts
Studies of bone marrow stromal cells have demonstrated that adipocytes and osteoblasts are closely Clinical and basic science studies suggest that an inverse relationship exists between adipocytes and osteoblasts in the bone marrow. Patients suffering from osteoporosis have more adipocytes in their marrow cavity compared to age-matched controls. At the same time, these patients have reduced bone mass. In vitro, adipogenic agents antagonize expression of osteoblast markers, such as osteocalcin. However, the adipocyte-derived hormone leptin promotes stromal cell expression of osteoblast genes. 16 These observations imply that a hormonalacytokine negative feedback loop within the bone marrow microenvironment may govern stromal cell commitment to the adipocyte vs the osteoblast pathway. Agents which promote adipogenesis block osteogenesis while secretory hormones derived from adipocytes promote osteoblast differentiation. While this may be an over-simpli®cation, it provides a working model for future experiments in this arena.
Adipose-derived osteoblasts
The presence of a multipotent stromal cell in the bone marrow suggests that similar stromal cells may exist elsewhere in the body. Preliminary data in our laboratory supports this hypothesis. In vitro, adipose tissue-derived stromal cells express osteocalcin and mineralize their extracellular matrix under osteogenic culture conditions. Studies are currently underway to examine the ability of adipose tissue-derived stromal cells to form bone in vivo.
Differentiation of stromal cells into other cell types
The differentiation potential of adipose tissue-derived stromal cells may not be limited to the osteoblast lineage. 13 Other mesenchymal lineage options should be explored. These include the chondrocyte, smooth muscle and skeletal muscle lineages. Each of these pathways should be inducible in vitro by inclusion of appropriate hormones and cytokines. This capability has direct clinical utility. For example, cartilage tissue heals poorly in adult patients due to a lack of local progenitor cells. To treat joint injuries, orthopedic surgeons must harvest cartilage from other sites in the patient, expand these limited numbers of cells in vitro, and then re-implant them directly into the damaged joint. The ability to use adipose tissuederived stromal cells would greatly reduce the expense of this procedure. Similarly, the ability to use`waste' adipose tissue to repair defects involving smooth or skeletal muscle would have wide application. Smooth muscle is required for normal bladder and intestinal function. When these tissues are lost due to trauma or cancer metastasis, patients must severely change their lifestyle. If surgeons could repair these organs using biomaterials with functional smooth muscle cells, they would greatly improve the quality of life in these individuals.
Summary
The hypothesis that adipose-derived stromal cells can be used to facilitate tissue repair has important clinical implications. Currently, investigators are evaluating bone marrow stromal cells to treat bone fractures and metabolic diseases. Harvesting these cells requires the patient to undergo a bone marrow biopsy, an invasive and potentially hazardous procedure. Moreover, only a limited number of cells can be obtained. In contrast, subcutaneous adipose tissue is abundant and easily accessible through liposuction. In the majority of adults, removal of 300 g or more of adipose tissue is feasible, yielding up to one billion cells. These quantities will allow an individual to cryopreserve their own stromal cells for future operations and procedures. Adipose tissue-derived stromal cells with osteogenic capability also have value in elective orthopedic and periodontal procedures. For example, in a hip replacement, the patient's own stromal cells could be delivered to the implant site as a paste with cytokines. Over 350 000 hip replacements are performed each year in the US and hip fracture is a major cause of morbidity and mortality in the elderly. These osteoblast-primed cells would improve bone repair and accelerate the patient's return to complete activity. Similar applications can be envisioned for bone losses due to tooth decay and osteoporosis.
